{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:39:26Z","timestamp":1792683566937,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resinv.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:38:12Z","timestamp":1760222292000},"page":"1250-1261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patient-related factors in advanced lung cancer: A review of ECOG-PS, malnutrition, and sarcopenia"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-6100","authenticated-orcid":false,"given":"Shun","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.10.005_bib1","first-page":"5605","article-title":"We report performance status in oncology-but not nutritional status?","volume":"28","author":"Aktas","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bjc.1993.140","article-title":"Performance status assessment in cancer patients. An inter-observer variability study","volume":"67","author":"Sorensen","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","article-title":"Diagnostic criteria for malnutrition- an ESPEN consensus statement","volume":"34","author":"Cederholm","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.resinv.2025.10.005_bib4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41430-018-0245-4","article-title":"Cancer-associated malnutrition","volume":"72","author":"Baracos","year":"2018","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.resinv.2025.10.005_bib5","doi-asserted-by":"crossref","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J Nutr"},{"key":"10.1016\/j.resinv.2025.10.005_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.eurger.2015.12.012","article-title":"Sarcopenia and the cardiometabolic syndrome: a narrative review","volume":"6","author":"Bahat","year":"2016","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1479972316679664","article-title":"Sarcopenia and frailty in chronic respiratory disease","volume":"14","author":"Bone","year":"2017","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.resinv.2025.10.005_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/DMSO.S186600","article-title":"Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship","volume":"12","author":"Mesinovic","year":"2019","journal-title":"Diab Metab Syndr Obes"},{"key":"10.1016\/j.resinv.2025.10.005_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.630009","article-title":"Sarcopenia is associated with increased risks of rotator cuff tendon diseases among community-dwelling elders: a cross-sectional quantitative ultrasound study","volume":"8","author":"Han","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/JTO.0000000000000690","article-title":"Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer","volume":"10","author":"Kim","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.lungcan.2016.08.007","article-title":"Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer","volume":"101","author":"Suzuki","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.resinv.2025.10.005_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.resinv.2025.10.005_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1054\/bjoc.2001.2162","article-title":"Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer","volume":"85","author":"Ando","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.21037\/tlcr-21-938","article-title":"The predictive utility of patient- reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy","volume":"11","author":"Badaoui","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.resinv.2025.10.005_bib17","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S1470-2045(12)70412-6","article-title":"First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy [TOPICAL]: a double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/annonc\/mdh087","article-title":"Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2:results of an european experts panel","volume":"15","author":"Gridelli","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1200\/JCO.2005.04.9452","article-title":"Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in eastern cooperative oncology group performance status 2 non-small-cell lung cancer patients:ECOG 1599","volume":"25","author":"Langer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100550","article-title":"Cytotoxic chemotherapy in advanced non- small cell lung cancer with poor performance status: a retrospective analysis from routine clinical practice","volume":"44","author":"Kancharla","year":"2020","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4103\/crst.crst_127_22","article-title":"ECOG performance status as a representative of deficits in older Indian patients with cancer: a cross-sectional analysis from a large cohort study","volume":"5","author":"Gattani","year":"2022","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.resinv.2025.10.005_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jpm.2006.9.309","article-title":"Objective evaluation of physical function in patients with advanced lung cancer: a preliminary report","volume":"9","author":"Montoya","year":"2006","journal-title":"J Palliat Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.resinv.2025.10.005_bib24","doi-asserted-by":"crossref","first-page":"79884","DOI":"10.18632\/oncotarget.20168","article-title":"Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study","volume":"8","author":"Muscaritoli","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.resinv.2025.10.005_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1753-4887.1996.tb03793.x","article-title":"Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation","volume":"54","author":"Guigoz","year":"1996","journal-title":"Nutr Rev"},{"key":"10.1016\/j.resinv.2025.10.005_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition \u2013 a consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.resinv.2025.10.005_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.ejcn.1601412","article-title":"Use of the scored patient generated subjective global assessment [PG-SGA] as a nutrition assessment tool in patients with cancer","volume":"56","author":"Bauer","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.resinv.2025.10.005_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr J"},{"key":"10.1016\/j.resinv.2025.10.005_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.734735","article-title":"Hypoalbuminaemia as a prognostic biomarker of first-line treatment resistance in metastatic non-small cell lung cancer","volume":"8","author":"Stares","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.resinv.2025.10.005_bib30","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1080\/07853890.2023.2192047","article-title":"Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence","volume":"55","author":"Zhang","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review","volume":"13","author":"Jafri","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib32","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1080\/01635581.2021.1960387","article-title":"The geriatric nutritional risk index and prognostic nutritional index predict the overall survival of advanced non-small cell lung cancer patients","volume":"74","author":"Matsuura","year":"2022","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2196089","article-title":"The prognostic nutritional index before durvalumab after chemoradiation predict the overall survival in patients with stage III non-small cell lung cancer","volume":"55","author":"Matsuura","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S0029665108007131","article-title":"An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer","volume":"67","author":"McMillan","year":"2008","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.resinv.2025.10.005_bib35","first-page":"38","article-title":"CONUT: a tool for controlling nutritional status. First validation in a hospital population","volume":"20","author":"Ignacio de Ulibarri","year":"2005","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.resinv.2025.10.005_bib36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdq440","article-title":"Baseline nutritional evaluation in metastatic lung cancer patients: mini nutritional assessment versus weight loss history","volume":"22","author":"Gioulbasanis","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.lungcan.2012.04.008","article-title":"The glasgow prognostic score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer","volume":"77","author":"Gioulbasanis","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib38","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.cllc.2015.03.005","article-title":"Advanced lung cancer inflammation index, a new prognostic score, predicts outcome in patients with small-cell lung cancer","volume":"16","author":"He","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib39","article-title":"Prognostic significance of modified advanced lung cancer inflammation index (ALI) in patients with small cell lung cancer_ comparison with original ALI","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2025.10.005_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cam4.1234","article-title":"Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer","volume":"7","author":"Shiroyama","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.37349\/etat.2023.00172","article-title":"Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer","volume":"4","author":"Mahajan","year":"2023","journal-title":"Explor Target Antitumor Ther"},{"key":"10.1016\/j.resinv.2025.10.005_bib42","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.945752","article-title":"Prognostic significance of the advanced lung cancer inflammation index in metastatic small cell lung cancer: a retrospective analysis of 96 patients","volume":"30","author":"\u00dcr\u00fcn","year":"2024","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.resinv.2025.10.005_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.lungcan.2012.04.008","article-title":"The glasgow prognostic score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer","volume":"77","author":"Gioulbasanis","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13277-014-2623-4","article-title":"A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer","volume":"36","author":"Zhou","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.resinv.2025.10.005_bib45","first-page":"249","article-title":"Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer","volume":"8","author":"Minami","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3892\/mco.2017.1261","article-title":"Modified Glasgow prognostic score in patients with small-cell lung cancer","volume":"7","author":"Kurishima","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clnesp.2020.08.003","article-title":"Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer","volume":"40","author":"Abbass","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.resinv.2025.10.005_bib48","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1111\/1759-7714.13526","article-title":"Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment","volume":"11","author":"Kasahara","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2152\/jmi.68.260","article-title":"Ability of the Glasgow prognostic score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancer","volume":"68","author":"Nakashima","year":"2021","journal-title":"J Med Investig"},{"key":"10.1016\/j.resinv.2025.10.005_bib50","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1002\/cam4.4220","article-title":"Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer","volume":"10","author":"Imai","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lungcan.2020.11.026","article-title":"Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors","volume":"152","author":"Takamori","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib52","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1159\/000532087","article-title":"The Glasgow prognostic score predicts survival outcomes in patients with extensive-stage small cell lung cancer","volume":"101","author":"Igawa","year":"2023","journal-title":"Oncology"},{"key":"10.1016\/j.resinv.2025.10.005_bib53","article-title":"Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer","volume":"12","author":"Wasamoto","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1159\/000530809","article-title":"The Glasgow prognostic score predicts survival in patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations who are treated with epidermal growth factor receptor-tyrosine kinase inhibitors","volume":"101","author":"Akazawa","year":"2023","journal-title":"Oncology"},{"key":"10.1016\/j.resinv.2025.10.005_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107505","article-title":"Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition","volume":"189","author":"Saal","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147226","article-title":"Low prognostic nutritional index correlates with worse survival in patients with advanced NSCLC following EGFR-TKIs","volume":"11","author":"Sheng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2025.10.005_bib57","first-page":"2273","article-title":"Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?","volume":"28","author":"Bozkaya","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4149\/neo_2019_190401N284","article-title":"Low pretreatment PNI correlates with worse survival in patients with stage III\/IV NSCLC who received chemotherapy","volume":"67","author":"Shen","year":"2020","journal-title":"Neoplasma"},{"key":"10.1016\/j.resinv.2025.10.005_bib59","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.7150\/jca.55936","article-title":"Prognostic nutritional index identifies risk of early progression and survival outcomes in advanced Non-small cell lung cancer patients treated with PD-1 inhibitors","volume":"12","author":"Liu","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/11795549221137134","article-title":"Combination of baseline and variation of prognostic nutritional index enhances the survival predictive value of patients with advanced non-small cell lung cancer treated with programmed cell death protein 1 inhibitor","volume":"16","author":"Fang","year":"2022","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib61","doi-asserted-by":"crossref","first-page":"14327","DOI":"10.1002\/cam4.6110","article-title":"Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients","volume":"12","author":"Oku","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib62","article-title":"Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region","volume":"13","author":"Wu","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib63","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.21037\/jtd.2019.09.29","article-title":"Prognostic impact of the controlling nutritional status score in patients with non-small cell lung cancer treated with pembrolizumab","volume":"11","author":"Ohba","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.resinv.2025.10.005_bib64","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00408-020-00361-2","article-title":"The significance of controlling nutritional status (CONUT) score as a novel prognostic parameter in small cell lung cancer","volume":"198","author":"Y\u0131lmaz","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.resinv.2025.10.005_bib65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12885-023-10682-z","article-title":"Controlling nutritional status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/01635581.2020.1743865","article-title":"The geriatric nutritional risk index predicts overall survival in geriatric patients with metastatic lung adenocarcinoma","volume":"73","author":"Tang","year":"2021","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12890-021-01782-2","article-title":"Association of the geriatric nutritional risk index with the survival of patients with non-small-cell lung cancer after platinum- based chemotherapy","volume":"21","author":"Karayama","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib68","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/1759-7714.13909","article-title":"Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy","volume":"12","author":"Sonehara","year":"2021","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.21873\/invivo.13454","article-title":"Association of geriatric nutritional risk index with immune checkpoint inhibitor treatment duration and adverse events in lung cancer","volume":"38","author":"Shimizu","year":"2024","journal-title":"In Vivo (Athens)"},{"key":"10.1016\/j.resinv.2025.10.005_bib70","doi-asserted-by":"crossref","first-page":"482","DOI":"10.21873\/cdp.10352","article-title":"Geriatric nutritional risk index as prognostic marker for elderly patients with small cell lung cancer","volume":"4","author":"Kinoshita","year":"2024","journal-title":"Cancer Diagn Progn"},{"key":"10.1016\/j.resinv.2025.10.005_bib71","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1159\/000536120","volume":"102","author":"Hirabayashi","year":"2024","journal-title":"Oncology"},{"key":"10.1016\/j.resinv.2025.10.005_bib72","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: european consensus on definition and diagnosis: report of the european working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.resinv.2025.10.005_bib73","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.chest.2019.04.115","article-title":"Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis","volume":"156","author":"Yang","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2025.10.005_bib74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12672-022-00576-0","article-title":"Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review","volume":"13","author":"Lin","year":"2022","journal-title":"Discov Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib75","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metabol"},{"key":"10.1016\/j.resinv.2025.10.005_bib76","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.nut.2016.04.003","article-title":"Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults","volume":"32","author":"Hamaguchi","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.resinv.2025.10.005_bib77","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jtho.2018.04.035","article-title":"Sarcopenia in resected NSCLC: effect on postoperative outcomes","volume":"13","author":"Nakamura","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib78","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12885-025-13728-6","article-title":"Lower-extremity muscle strength is associated with prognosis in patients with advanced or recurrent lung cancer: a retrospective, observational study","volume":"25","author":"Fukushima","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111258","article-title":"Comparison of the AWGS and optimal stratification- defined handgrip strength thresholds for predicting survival in patients with lung cancer","volume":"90","author":"Yin","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.resinv.2025.10.005_bib81","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00432-020-03146-5","article-title":"Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors","volume":"146","author":"Takada","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib82","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.21037\/atm-21-6578","article-title":"Assessment of sarcopenia as a predictor of poor overall survival for advanced non-small-cell lung cancer patients receiving salvage anti-PD-1 immunotherapy","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib83","article-title":"Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis","volume":"11","author":"Katsui","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2025.10.005_bib84","doi-asserted-by":"crossref","first-page":"982","DOI":"10.17305\/bjbms.2022.7147","article-title":"The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma","volume":"22","author":"Topcu","year":"2022","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.resinv.2025.10.005_bib85","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/1759-7714.15017","article-title":"Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-Mutated NSCLC treated with afatinib","volume":"14","author":"Wu","year":"2023","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib86","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1111\/1759-7714.15443","article-title":"Impact of sarcopenia on the prognosis of patients with advanced non-small cell lung cancer treated with antiangiogenic therapy: a propensity score matching analysis","volume":"15","author":"Huang","year":"2024","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62825-2","article-title":"Prognostic significance of CT-determined sarcopenia in older patients with advanced squamous cell lung cancer treated with programmed death-1 inhibitors","volume":"14","author":"Ying","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2025.10.005_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1450020","article-title":"Sarcopenia predicts immune-related adverse events due to anti-PD-1\/PD-L1 therapy in patients with advanced lung cancer","volume":"14","author":"Xue","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib89","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4143\/crt.2024.493","article-title":"Unraveling the impact of sarcopenia-induced lymphopenia on treatment response and prognosis in patients with stage III non\u2013small cell lung cancer: insights for optimizing chemoradiation and immune checkpoint inhibitor","volume":"57","author":"Lee","year":"2025","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.resinv.2025.10.005_bib90","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12885-025-13772-2","article-title":"Predictive model for sarcopenia in patients with non-small cell lung cancer and malignant pleural effusion","volume":"25","author":"Gao","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib91","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/s41598-019-39120-6","article-title":"Impact of sarcopenia in patients with advanced non\u2013small cell lung cancer treated with PD-1 inhibitors: a preliminary retrospective study","volume":"9","author":"Shiroyama","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2025.10.005_bib92","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14740\/wjon1244","article-title":"Low body mass index is an independent prognostic factor in patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitor","volume":"10","author":"Minami","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14740\/wjon1289","article-title":"Sarcopenia and visceral adiposity are not independent prognostic markers for extensive disease of small-cell lung cancer: a single-centered retrospective cohort study","volume":"11","author":"Minami","year":"2020","journal-title":"World J Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14740\/wjon1225","article-title":"Sarcopenia and visceral adiposity did not affect efficacy of immune-checkpoint inhibitor monotherapy for pretreated patients with advanced non-small cell lung cancer","volume":"11","author":"Minami","year":"2020","journal-title":"World J Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.986236","article-title":"Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy","volume":"12","author":"Bolte","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.resinv.2025.10.005_bib96","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/1759-7714.14294","article-title":"Impact of sarcopenia on chemotherapy-triggered exacerbation of interstitial lung disease in patients with non-small cell lung cancer","volume":"13","author":"Kikuchi","year":"2022","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.resinv.2025.10.005_bib97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cam4.3631","article-title":"Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer","volume":"10","author":"Nishioka","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.resinv.2025.10.005_bib98","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.clnu.2023.10.006","article-title":"Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer","volume":"42","author":"Zhang","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.resinv.2025.10.005_bib99","article-title":"Measurement of sarcopenia in lung cancer inpatients and its association with frailty, nutritional risk, and malnutrition","volume":"10","author":"Wang","year":"2023","journal-title":"Front Nutr"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:03:44Z","timestamp":1763625824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525001649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2212534525001649"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.10.005","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-related factors in advanced lung cancer: A review of ECOG-PS, malnutrition, and sarcopenia","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}